Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 732 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Nivolumab Plus Low-Dose Ipilimumab Demonstrates Clinical Benefit in First-Line Treatment for... October 20, 2021 Failed Alzheimer’s Drug Might Boost CAR T-Cell Therapy for Multiple Myeloma October 25, 2019 Keeping progress in oncology on the agenda: ESMO honours recipients of... December 3, 2020 Study Says Gold Particles Injected into Tumors May Improve Cancer Patients’... June 29, 2021 Load more HOT NEWS Olivia Newton-John Talks About Her Use Of Medical Cannabis During Cancer... Can Chemotherapy Drugs Be Designed to Avoid Side Effects? Corgi Named Dolly Didn’t Win At Westminster, But Is A Champion... EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab
